Inventor · disambiguated record
Roman Kischel
Also filed as: KISCHEL ROMAN
21 granted patents·22 pending applications·552 citations·filing 2001–2025
95Inventor score
Top patents by PatentIndex Score
43 records- 0198US9340621B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2012·Granted May 17, 2016·91 cites·15 claims
- 0297US9150664B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2012·Granted Oct 6, 2015·64 cites·15 claims
- 0395US11472886B2Cross-species-specific PSMAxCD3 bispecific single chain antibodyAMGEN RES MUNICH GMBH·Filed 2021·Granted Oct 18, 2022·3 cites·13 claims
- 0495US8236308B2Composition comprising cross-species-specific antibodies and uses thereofKISCHEL ROMAN·Filed 2006·Granted Aug 7, 2012·238 cites·9 claims
- 0594US9598500B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2012·Granted Mar 21, 2017·22 cites·15 claims
- 0692US10766969B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2012·Granted Sep 8, 2020·8 cites·29 claims
- 0792US8784821B1Human-anti-human cd3 binding moleculesKUFER PETER·Filed 2004·Granted Jul 22, 2014·63 cites·23 claims
- 0890US12281176B2Binding molecules for BCMA and CD3AMGEN INC·Filed 2021·Granted Apr 22, 2025·1 cites·7 claims
- 0990US10752694B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2014·Granted Aug 25, 2020·11 cites·15 claims
- 1090US9587036B2Cross-species-specific PSMAxCD3 bispecific single chain antibodyKUFER PETER·Filed 2011·Granted Mar 7, 2017·24 cites·34 claims
- 1188US11987633B2Cross-species-specific single domain bispecific single chain antibodyAMGEN RES MUNICH GMBH·Filed 2021·Granted May 21, 2024·1 cites·27 claims
- 1288US9260522B2Bispecific single chain antibodies with specificity for high molecular weight target antigensKUFER PETER·Filed 2009·Granted Feb 16, 2016·7 cites·4 claims
- 1387US10059766B2Antibody constructs for CDH19 and CD3AMGEN RES MUNICH GMBH·Filed 2014·Granted Aug 28, 2018·9 cites·17 claims
- 1485US10981998B2Cross-species-specific single domain bispecific single chain antibodyKUFER PETER·Filed 2009·Granted Apr 20, 2021·5 cites·18 claims
- 1583US10047159B2Bispecific single chain antibodies with specificity for high molecular weight target antigensAMGEN RES MUNICH GMBH·Filed 2016·Granted Aug 14, 2018·3 cites·18 claims
- 1683US2025064927A1Compositions comprising cross-species-specific antibodies and uses thereofAMGEN RES MUNICH GMBH·Filed 2024·Application pending·0 cites
- 1781US2022251243A1Binding molecules for bcma and cd3AMGEN INC·Filed 2022·Application pending·0 cites
- 1879US11498964B2Antibody constructs for CDH19 and CD3AMGEN RES MUNICH GMBH·Filed 2018·Granted Nov 15, 2022·1 cites·17 claims
- 1978US12441796B2Antibody constructs for CDH19 and CD3AMGEN INC·Filed 2022·Granted Oct 14, 2025·0 cites·17 claims
- 2078US2025346684A1Binding molecules for bcma and cd3AMGEN INC·Filed 2025·Application pending·0 cites
- 2176US12281175B2Binding molecules for BCMA and CD3AMGEN INC·Filed 2020·Granted Apr 22, 2025·0 cites·16 claims
- 2275US12281172B2Cross-species-specific PSMAxCD3 bispecific single chain antibodyAMGEN RES MUNICH GMBH·Filed 2021·Granted Apr 22, 2025·0 cites·18 claims
- 2374US2025163179A1CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODYAMGEN RES MUNICH GMBH·Filed 2025·Application pending·0 cites
- 2471US11925684B2Compositions comprising cross-species-specific antibodies and uses thereofAMGEN RES MUNICH GMBH·Filed 2018·Granted Mar 12, 2024·0 cites·16 claims
- 2569US11053318B2Administration of a bispecific construct binding to CD33 and CD3 for use in a method for the treatment of myeloid leukemiaAMGEN RES MUNICH GMBH·Filed 2017·Granted Jul 6, 2021·1 cites·5 claims
- 2667US2011293619A1CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODYKUFER PETER·Filed 2009·Application pending·0 cites
- 2764US2020095319A1Cross-species-specific bispecific bindersAMGEN RES MUNICH GMBH·Filed 2019·Application pending·0 cites
- 2864US2023357444A1Cross-species-specific binding domainAMGEN RES MUNICH GMBH·Filed 2022·Application pending·0 cites
- 2963US2010183615A1Cross-species-specific bispecific bindersMICROMET AG·Filed 2008·Application pending·0 cites
- 3062US2020071405A1Antibody constructs for cdh19 and cd3AMGEN RES MUNICH GMBH·Filed 2019·Application pending·0 cites
- 3161US2020362039A1Cross-species-specific pscaxcd3, cd19xcd3, c-metxcd3, endosialinxcd3, epcamxcd3, igf-1rxcd3 or fapalphaxcd3 bispecific single chain antibodyAMGEN RES MUNICH GMBH·Filed 2019·Application pending·0 cites
- 3261US2019169310A1CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODYAMGEN RES MUNICH GMBH·Filed 2018·Application pending·0 cites
- 3361US2019040133A1Bispecific single chain antibodies with specificity for high molecular weight target antigensAMGEN RES MUNICH GMBH·Filed 2018·Application pending·0 cites
- 3459US2012034228A1CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODYKUFER PETER·Filed 2009·Application pending·0 cites
- 3557US2013129729A1Compositions comprising cross-species-specific antibodies and uses thereofKISCHEL ROMAN·Filed 2012·Application pending·0 cites
- 3656US2012244162A1Cross-species-specific bispecific bindersKUFER PETER·Filed 2012·Application pending·0 cites
- 3753US2016152707A1Cross-species-specific bispecific bindersAMGEN RES MUNICH GMBH·Filed 2015·Application pending·0 cites
- 3849US2010150918A1Cross-species-specific binding domainMICROMET AG·Filed 2008·Application pending·0 cites
- 3949US2021301017A1Prolonged administration of a bispecific antibody construct binding to cd33 and cd3AMGEN RES MUNICH GMBH·Filed 2019·Application pending·0 cites
- 4047US2022403035A1Multitargeting antigen-binding molecules for use in proliferative diseasesAMGEN RES MUNICH GMBH·Filed 2020·Application pending·0 cites
- 4145US2007122852A1Method for identifying antigen specific b cellsMICROMET AG·Filed 2003·Application pending·0 cites
- 4244US2006235201A1Enduring T cell responseKISCHEL ROMAN·Filed 2004·Application pending·0 cites
- 4336US2004038339A1Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complexFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roman Kischel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →